Companies: 48,874 Total Market Cap: 132486345765638.30

Aurora Cannabis

NASDAQ: ACB
Healthcare Drug Manufacturers - Specialty & Generic
Rank #17487
Market Cap 280.93 M
Volume 1.74 M
Price 5.13
Change (%) 3.43%
Country or region Canada Canada

Aurora Cannabis's latest marketcap:

280.93 M

As of 05/19/2025, Aurora Cannabis's market capitalization has reached $280.93 M. According to our data, Aurora Cannabis is the 17487th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 280.93 M
Revenue (ttm) 222.96 M
Net Income (ttm) 3.49 M
Shares Out 54.88 M
EPS (ttm) 0.07
Forward PE 26.33
Ex-Dividend Date n/a
Earnings Date 06/20/2025
Market Cap Chart
Data Updated: 05/19/2025

Aurora Cannabis's yearly market capitalization.

Aurora Cannabis has seen its market value drop from $19.36 B to $280.93 M since 2017, representing a total decrease of 98.55% and an annual compound decline rate (CAGR) of 41.52%.
Date Market Cap Change (%)
05/19/2025 $280.93 M 14.15%
12/31/2024 $233.20 M 16.43%
12/29/2023 $200.30 M -27.74%
12/30/2022 $277.20 M -74.14%
12/31/2021 $1.07 B -3.31%
12/31/2020 $1.11 B -50.11%
12/31/2019 $2.22 B -55.11%
12/31/2018 $4.95 B -74.43%
06/29/2017 $19.36 B

Company Profile

Aurora Cannabis was founded in 2013 in Canada. on the Nasdaq Stock Market. With 1073 employees, it focuses on Healthcare and aims to drive innovation in Drug Manufacturers - Specialty & Generic.
Frequently Asked Questions

As of 05/19/2025, Aurora Cannabis (including the parent company, if applicable) has an estimated market capitalization of $280.93 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Aurora Cannabis global market capitalization ranking is approximately 17487 as of 05/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Canada
Founded 2013
IPO Date n/a
Employees 1,073
CEO
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Address
Website